Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Pamela S Whitten a Department of
Telecommunications, Michigan State University, East Lansing, MI
48824-1212, USA, b Department of Primary Care, University of Liverpool, c Department of
Pharmacology, University of Liverpool, d Centre for Health Services
Research, University of Newcastle-upon-Tyne, e School of Primary
Care, University of Manchester
Correspondence to: P S
Whitten pwhitten{at}msu.edu
Objectives:
To systematically review cost benefit
studies of telemedicine.
What is already known on this topic
Hundreds of articles have been published claiming that telemedicine is
cost effective However, missing from the literature is a synthesis or meta-analysis of
these publications What this study adds
Only 4% of these articles met quality criteria justifying inclusion in
a formalised quality review, and most of these were small scale, short
term, pragmatic evaluations with few generalisable
conclusions There is little published evidence to confirm whether or not
telemedicine is a cost effective alternative to standard healthcare
delivery
Design:
Systematic review of English language, peer reviewed journal articles.
Data sources:
Searches of Medline, Embase, ISI
citation indexes, and database of Telemedicine Information Exchange.
Studies selected:
55 of 612 identified articles that
presented actual cost benefit data.
Main outcome measures:
Scientific quality of reports
assessed by use of an established instrument for adjudicating on the
quality of economic analyses.
Results:
557 articles without cost data categorised by topic. 55 articles with data initially categorised by cost variables
employed in the study and conclusions. Only 24/55 (44%) studies met
quality criteria justifying inclusion in a quality review. 20/24 (83%)
restricted to simple cost comparisons. No study used cost utility
analysis, the conventional means of establishing the "value for
money" that a therapeutic intervention represents. Only 7/24 (29%)
studies attempted to explore the level of utilisation that would be
needed for telemedicine services to compare favourably with
traditionally organised health care. None addressed this question in
sufficient detail to adequately answer it. 15/24 (62.5%) of articles
reviewed here provided no details of sensitivity analysis, a method all
economic analyses should incorporate.
Conclusion:
There is no good evidence that
telemedicine is a cost effective means of delivering health care.
The use of telemedicine has garnered much attention in the past
decade
A comprehensive literature search of cost related articles on
telemedicine identified more than 600 articles, but only 9% contained
any cost benefit data
Read all Rapid Responses